首页> 美国卫生研究院文献>British Heart Journal >Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study

【2h】

Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study

机译：使用EUROPA研究的数据培哚普利降低稳定型冠心病患者心血管事件的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) trial has recently reported.

机译：背景技术最近报道了在稳定的冠状动脉疾病（EUROPA）试验中使用培哚普利减少心脏事件的EUropean试验。

著录项

期刊名称 British Heart Journal
作者
Andrew Briggs; Borislava Mihaylova; Mark Sculpher; Alistair Hall; Jane Wolstenholme; Maarten Simoons; Jaap Deckers; Roberto Ferrari; Willem J Remme; Michel Bertrand; Kim Fox;
展开▼
作者单位

展开▼
年(卷),期 2007(93),9
年度 2007
页码 1081–1086
总页数 6
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
cost–benefit analysis hypertension cardiovascular diseases;

机译：成本效益分析;高血压;心血管疾病;

相似文献

外文文献
中文文献
专利

1. Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study [J] . Andrew Briggs, Borislava Mihaylova, Mark Sculpher, Heart . 2007,第9期

机译：使用EUROPA研究的数据，培哚普利降低稳定型冠心病患者心血管事件的成本效益
2. Perindopril and beta-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis [J] . Bertrand Michel E., Ferrari Roberto, Remme Willem J., The American heart journal . 2015,第6期

机译：培哚普利和β受体阻滞剂在稳定冠心病患者中预防心脏事件和死亡率：一项在稳定冠状动脉疾病（EUROPA）亚分析中使用培哚普利减少心脏事件的EUropean试验
3. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). [J] . Fox KM The Lancet . 2003,第9386期

机译：培哚普利在稳定冠心病患者中减少心血管事件的功效：随机，双盲，安慰剂对照，多中心试验（EUROPA研究）。
4. Differential hypertension control among patients with established coronary heart disease: The European Action on Secondary Prevention through Intervention to Reduce Events (EURO-ASPIRE) II study [C] . J Heidrich, HW Hense, D de Baquer, Nordrhein-Westfa?lische Akademie der Wissenschaften . 2005

机译：冠心病患者的差分高血压控制：通过干预减少事件的欧洲级预防措施（欧洲宣传）II研究
5. A comparison of selected preoperative coronary artery disease risk factors in patients 40 years or younger and patients over 40 years undergoing coronary artery bypass graft surgery. [D] . Frye, Laurie Perry. 2002

机译：比较40岁以下的患者和40岁以上进行冠状动脉搭桥术的患者的术前选择的冠心病危险因素。
6. Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement? [O] . Jasmine A. Luzum, David E. Lanfear 2016

机译：培哚普利在稳定冠状动脉疾病中的临床药效学和成本效益的药物遗传学风险评分：我们何时准备实施？
7. Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. [O] . Briggs, A, Mihaylova, B, Sculpher, M, 2007

机译：使用EUROPA研究的数据，培哚普利降低稳定型冠心病患者心血管事件的成本效益。

Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study

摘要

著录项

相似文献

相关主题

期刊订阅